NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 5.10% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 4.72% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | null | null | 4.06% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.45% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.41% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.04% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.68% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.57% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.39% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 2.22% |
| TECH | Bio-Techne Corp | Healthcare | Biotechnology | 2.13% |
| RGEN | Repligen Corporation | Healthcare | Medical Instruments & Supplies | 2.13% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.10% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 1.98% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.83% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.82% |